( May 12, 2026, 2:57 PM EDT) -- WASHINGTON, D.C. — The District of Columbia Circuit Court of Appeals on May 11 affirmed a lower court’s dismissal of a relator’s qui tam suit alleging violations of the False Claims Act (FCA) and similar state and District of Columbia laws related to outpatient opioid treatment centers’ billing to government insurers for alleged unnecessary urine drug tests and the use of unlicensed addiction counselors, finding in part that the relator “failed to sufficiently allege that false claims based on medically unnecessary urine drug tests were submitted to the government for payment.”...